Carboplatin plus pemetrexed for the elderly incurable chemo-naive nonsquamous non-small cell lung cancer: Meta-analysis.

about

Carboplatin plus pemetrexed for the elderly incurable chemo-naive nonsquamous non-small cell lung cancer: Meta-analysis.

Item

http://www.wikidata.org/entity/Q47188669

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Carboplatin plus pemetrexed fo ...... ll lung cancer: Meta-analysis.

@en

Carboplatin plus pemetrexed fo ...... ll lung cancer: Meta-analysis.

@nl

type

Item

label

Carboplatin plus pemetrexed fo ...... ll lung cancer: Meta-analysis.

@en

Carboplatin plus pemetrexed fo ...... ll lung cancer: Meta-analysis.

@nl

prefLabel

Carboplatin plus pemetrexed fo ...... ll lung cancer: Meta-analysis.

@en

Carboplatin plus pemetrexed fo ...... ll lung cancer: Meta-analysis.

@nl

P1476

Carboplatin plus pemetrexed fo ...... ell lung cancer: Meta-analysis

@en

P2093

Akimichi Nagashima

http://www.w3.org/2001/XMLSchema#string

Masaru Ito

http://www.w3.org/2001/XMLSchema#string

Takeshi Kaneko

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Measuring inconsistency in meta-analyses

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

The nuts and bolts of PROSPERO: an international prospective register of systematic reviews

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Phase I study of carboplatin combined with pemetrexed for elderly patients with advanced non-squamous non-small cell lung cancer.

PRONOUNCE: randomized, open-label, phase III study of first-line pemetrexed + carboplatin followed by maintenance pemetrexed versus paclitaxel + carboplatin + bevacizumab followed by maintenance bevacizumab in patients ith advanced nonsquamous non-s

A phase II study of pemetrexed plus carboplatin followed by maintenance pemetrexed as first-line chemotherapy for elderly patients with advanced non-squamous non-small cell lung cancer.

P304

e3-e10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1111/AJCO.12837

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nobuyuki Horita

P577

2018-01-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29316288

http://www.w3.org/2001/XMLSchema#string